|
Championing the Eviosys principle of global leader and local partner, the giant in the sustainable packaging industry has invested €8 million in expanding the capacity of production of two-piece cans in three factories: Alcochete (Portugal), Murcia and Ribadumia (Spain).
The investment comes as the growing need for two-piece and EOE round and irregular cans in aluminum and steel in the fish, meat and pet food markets continues to increase. The fish market alone has grown in demand, +3.8% in 2022[1], highlighting the need for a reliable, sustainable, and local packaging manufacturer.
Working closely with partners in Spain and Portugal, Eviosys has seen these highly dynamic markets, rapidly change with consumer trends. As the leader in the canned fish segment, Eviosys has taken proactive steps to ensure businesses in the regions are able to access all of their packaging needs to respond to these trends, supplying end consumers.
To support the additional production capabilities of the factories, investment has been directed into custom printing and bolstered logistics support, meaning Eviosys customers can holistically grow their product production and delivery.
As Eviosys continues to grow in 2023, this investment reinforces its leadership in the Iberian Peninsula. The expanded capacity will allow Eviosys to continue delivering the best level of service to local customers. Investing in solutions to always provide customers with the best services and to ensure they can grow is at the core of Eviosys' mission.
Tomás Lopez, Chief Executive Officer, Eviosys, said:
"Our investment in the region showcases our commitment to our core principle of being a global leader and local partner. In 2023 and beyond, we'll continue to grow with our partners in the region, supporting them in what is a dynamic, fast-moving market, ensuring they can deliver for their customers."
Notes to Editors
To request further information, images, or interviews, please contact: eviosys@grayling.com
About Eviosys:
Eviosys is a leading global supplier of metal packaging, producing food cans and ends, aerosol cans, metal closures and promotional packaging to preserve the products of hundreds of consumer brands.
Eviosys has the largest manufacturing footprint in Europe, the Middle East and Africa (EMEA) with 6,700 employees in 45 manufacturing facilities across 18 countries. In 2022, it generated €2.7 billion in revenue. Eviosys is a portfolio company of KPS Capital Partners, LP.
For more information, visit www.eviosys.com.
[1] Shelf Stable Seafood (Source: Euromonitor)
Contact Information:
Maisie Jenyon PR Manager eviosysuk@grayling.com
Source: Eviosys
Sectors: Metals & Mining, Print & Package
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network. |
Related NewsEviosys Opens Luncheon Meat Can Line in Turkiye KARACABEY, TURKEY, Mar 23, 2023 - (ACN Newswire) - Eviosys announces the launch in Turkiye of a rectangular can manufacturing line for luncheon meat packaging, in response to customer demand indicating an expanding meat market. Backed by an investment |
Latest Newsトヨタ、米国生産トヨタ車の26年からの日本導入を検討 豊田, Dec 19, 2025 - (JCN Newswire) - トヨタ自動車株式会社は、米国で生産するカムリ（Camry）、ハイランダー（Highlander）、タンドラ（Tundra）の3車種について、2026年から順次、日本市場への導入を目指します。 Air T, Inc. Announces Closing of Regional Express Acquisition MINNEAPOLIS, MN, Dec 19, 2025 - (ACN Newswire) - Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia's leading regional airline. Air T now owns 100% of Fujitsu to showcase mobility and physical AI tech at CES 2026 KAWASAKI, Japan, Dec 19, 2025 - (JCN Newswire) - Fujitsu today announced that it will be exhibiting its mobility solutions and physical AI technology at the Consumer Electronics Show (CES) 2026, which will be held at the Las Vegas Convention Center (LVCC) TruMerit与NAPNAP携手开发全球儿科护理微认证 PHILADELPHIA, PA, Dec 18, 2025 - (ACN Newswire) - 全球领先的国际资质评估机构TruMerit（致力于支持医疗工作者职业发展）与美国儿科执业护士协会（NAPNAP，儿科执业护士教育领域的领导者®）宣布，双方将联合开发全球微认证项目，以提升全球儿科护理人员的知识与技能水平。 キリンと富士通、創薬DX技術を活用し、AIと実試験でシチコリンの腸脳作用メカニズムを解明 東京, Dec 17, 2025 - (JCN Newswire) - キリンホールディングス株式会社（代表取締役社長 COO 南方健志、以下キリン）のヘルスサイエンス研究所（所長 村島弘一郎）と富士通株式会社（代表取締役社長 時田隆仁、以下富士通）は、食品の新たな機能創出を目指し、AIを活用した創薬DX技術（注1）の一つであるQSP（定量的システム薬理学）（注2）モデルを用いた食品機能性シミュレーションに関する共同研究を実施しました。 |
|